Compare APGE & PFSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | APGE | PFSI |
|---|---|---|
| Founded | 2022 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Finance: Consumer Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.7B | 4.0B |
| IPO Year | 2023 | 2018 |
| Metric | APGE | PFSI |
|---|---|---|
| Price | $134.75 | $75.74 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 13 | 9 |
| Target Price | $109.67 | ★ $128.11 |
| AVG Volume (30 Days) | ★ 1.2M | 665.8K |
| Earning Date | 05-12-2026 | 05-05-2026 |
| Dividend Yield | N/A | ★ 1.35% |
| EPS Growth | N/A | ★ 59.25 |
| EPS | N/A | ★ 1.94 |
| Revenue | N/A | ★ $984,629,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $16.96 |
| P/E Ratio | ★ N/A | $39.61 |
| Revenue Growth | N/A | ★ 3.05 |
| 52 Week Low | $35.39 | $71.68 |
| 52 Week High | $134.88 | $160.36 |
| Indicator | APGE | PFSI |
|---|---|---|
| Relative Strength Index (RSI) | 77.42 | 42.07 |
| Support Level | $134.03 | $71.68 |
| Resistance Level | $134.88 | $87.46 |
| Average True Range (ATR) | 0.20 | 2.08 |
| MACD | -0.75 | 0.01 |
| Stochastic Oscillator | 87.65 | 34.36 |
Apogee Therapeutics Inc is a clinical-stage biotechnology company engaged in advancing optimized, novel biologics with the potential for differentiated efficacy and dosing in the inflammatory and immunology (I&I) markets, including for the treatment of atopic dermatitis (AD), asthma, eosinophilic esophagitis (EoE), chronic obstructive pulmonary disease (COPD), and other I&I indications. . Its antibody programs are designed to overcome the limitations of existing therapies by targeting well-established mechanisms of action and incorporating antibody engineering to optimize half-life and other properties.
PennyMac Financial Services Inc is a specialty financial services firm with a comprehensive mortgage platform mainly focused on the production and servicing of U.S. residential mortgage loans. The firm is also engaged in managing investments related to the U.S. mortgage market and provides products and services that leverage technologies to support customers. The company operates through two reportable operating segments: production and servicing. The production segment performs loan origination, acquisition, and sale activities, while the servicing segment performs servicing and subservicing of loans, early buyout transactions, and servicing of loans sourced and managed for PMT. The majority of revenue comes from the production segment.